Alendronate: Difference between revisions

From Proteopedia
Jump to navigationJump to search
No edit summary
No edit summary
Line 15: Line 15:
== Structure and General Function ==
== Structure and General Function ==
[[Image:Alendronate.gif]]<ref>Image from: http://pharmacy-and-drugs.com</ref>  
[[Image:Alendronate.gif]]<ref>Image from: http://pharmacy-and-drugs.com</ref>  


Alendronate is an aminobisphosphonate with a nonhydrolyzable P-C-P. Alendronate generally affects the activity of osteoclasts in bone. Osteoclasts are responsible for breaking down bone and also for bone resorption (losing bone substance). <ref>http://www.medterms.com/script/main/art.asp?articlekey=11794</ref> When alendronate is present, bone resorption is inhibited and bone breakdown is diminished.     
Alendronate is an aminobisphosphonate with a nonhydrolyzable P-C-P. Alendronate generally affects the activity of osteoclasts in bone. Osteoclasts are responsible for breaking down bone and also for bone resorption (losing bone substance). <ref>http://www.medterms.com/script/main/art.asp?articlekey=11794</ref> When alendronate is present, bone resorption is inhibited and bone breakdown is diminished.     
Line 45: Line 44:


The deactivation of FPPS causes a disruption of prenylation in the cell and thus affects various GTPases. For instance, it will incorrectly activate the GTPases Rho, Rac, and Cdc42.<ref>http://www.ncbi.nlm.nih.gov/pubmed/16734383</ref> The inhibition of post-translational prenylation of Ras is likely to cause cell apoptosis. <ref>http://www.ncbi.nlm.nih.gov/pubmed/9556058</ref>  
The deactivation of FPPS causes a disruption of prenylation in the cell and thus affects various GTPases. For instance, it will incorrectly activate the GTPases Rho, Rac, and Cdc42.<ref>http://www.ncbi.nlm.nih.gov/pubmed/16734383</ref> The inhibition of post-translational prenylation of Ras is likely to cause cell apoptosis. <ref>http://www.ncbi.nlm.nih.gov/pubmed/9556058</ref>  


==== FPPS Substrate ====
==== FPPS Substrate ====